新华医疗：华检医疗推进医疗创新药RWA交易所生态及配套稳定币体系

Core Viewpoint - Xinhua Medical (600587) is exploring potential synergies and capital efficiency improvements through its subsidiary Huajian Medical's initiatives in the medical innovation sector, particularly with the RWA exchange ecosystem and stablecoin system [1] Group 1 - Huajian Medical is advancing a medical innovation drug asset RWA exchange ecosystem, which is seen as a promising development avenue [1] - The company is considering the establishment of related funds and is actively pursuing operational licenses in the United States [1] - Xinhua Medical acknowledges the potential for these initiatives to enhance the overall capital efficiency and global presence of the group [1]